166 related articles for article (PubMed ID: 2963230)
21. [Biochemical modulation with sequential methotrexate (MTX)-5-fluorouracil (5-FU) treatment].
Ota K; Murakami M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1642-9. PubMed ID: 3496047
[TBL] [Abstract][Full Text] [Related]
22. Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response.
Benz C; DeGregorio M; Saks S; Sambol N; Holleran W; Ignoffo R; Lewis B; Cadman E
Cancer Res; 1985 Jul; 45(7):3354-8. PubMed ID: 4005858
[TBL] [Abstract][Full Text] [Related]
23. Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM).
Colucci G; Maiello E; Leo S; Giuliani F; Pedicini A; Pezzella G; Valori V; Galetta D; Contillo A; Prete F
Anticancer Res; 1994; 14(5B):2157-62. PubMed ID: 7840516
[TBL] [Abstract][Full Text] [Related]
24. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
25. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
26. A phase II trial of 5-fluorouracil and high-dose leucovorin in gastric carcinoma and a phase I trial of intraperitoneal 5-fluorouracil and leucovorin.
Arbuck SG; Douglass HO; Trave F; Rustum YM
NCI Monogr; 1987; (5):203-5. PubMed ID: 3501544
[TBL] [Abstract][Full Text] [Related]
27. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.
Tournigand C; Cervantes A; Figer A; Lledo G; Flesch M; Buyse M; Mineur L; Carola E; Etienne PL; Rivera F; Chirivella I; Perez-Staub N; Louvet C; André T; Tabah-Fisch I; de Gramont A
J Clin Oncol; 2006 Jan; 24(3):394-400. PubMed ID: 16421419
[TBL] [Abstract][Full Text] [Related]
28. Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial.
Abad A; Garcia P; Gravalos C; Tusquets I; Font A; Perez G; Cortés-Funes H; Fabregat X; Barnadas A; Rosell R
Cancer; 1995 Mar; 75(6):1238-44. PubMed ID: 7882275
[TBL] [Abstract][Full Text] [Related]
29. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.
Doroshow JH; Multhauf P; Leong L; Margolin K; Litchfield T; Akman S; Carr B; Bertrand M; Goldberg D; Blayney D
J Clin Oncol; 1990 Mar; 8(3):491-501. PubMed ID: 2407810
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapy protocol for metastasizing colorectal carcinoma. Methotrexate, 5-fluorouracil and cytarabine].
Dias Wickramanayake P; Klein HO; Pape S; Meyer-Hofmann H
Dtsch Med Wochenschr; 1985 Mar; 110(13):487-91. PubMed ID: 3979285
[TBL] [Abstract][Full Text] [Related]
31. Preliminary analysis of a randomized comparison of 5-fluorouracil versus 5-fluorouracil and high-dose continuous-infusion folinic acid in disseminated colorectal cancer.
Doroshow JH; Bertrand M; Newman E; Multhauf P; Leong L; Blayney D; Goldberg D; Margolin K; Carr B; Akman S
NCI Monogr; 1987; (5):171-4. PubMed ID: 3501538
[TBL] [Abstract][Full Text] [Related]
32. [Sequential methotrexate and fluorouracil in metastasizing colorectal carcinomas. Results of a phase II pilot study (author's transl)].
Herrmann R; Manegold C; Holzmann K; Fritze D
Dtsch Med Wochenschr; 1982 Apr; 107(13):491-3. PubMed ID: 7060484
[TBL] [Abstract][Full Text] [Related]
33. Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.
Nordic Gastrointestinal Tumor Adjuvant Therapy Group
J Clin Oncol; 1989 Oct; 7(10):1437-46. PubMed ID: 2674332
[TBL] [Abstract][Full Text] [Related]
34. [Current status of chemotherapy for colonic, rectal and anal carcinoma].
Herrmann R
Schweiz Rundsch Med Prax; 1990 Jul; 79(29-30):896-8. PubMed ID: 2374860
[TBL] [Abstract][Full Text] [Related]
35. Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer.
Kemeny N; Schneider A; Martin DS; Colofiore J; Sawyer RC; Derby S; Salvia B
Cancer Res; 1989 Aug; 49(16):4636-9. PubMed ID: 2472883
[TBL] [Abstract][Full Text] [Related]
36. Sequential methotrexate and fluorouracil in colon cancer.
Bertino JR; Marsh JC
J Clin Oncol; 1992 May; 10(5):865. PubMed ID: 1569456
[No Abstract] [Full Text] [Related]
37. Sequential methotrexate--5-FU--leucovorin (MFL) in advanced colorectal cancer.
Glimelius B; Ginman C; Graffman S; Påhlman L; Ståhle E
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):295-300. PubMed ID: 3486768
[TBL] [Abstract][Full Text] [Related]
38. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group.
Glimelius B
Ann Oncol; 1993 Mar; 4(3):235-40. PubMed ID: 8471555
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer.
Panasci L; Ford J; Margolese R
Cancer Chemother Pharmacol; 1985; 15(2):164-6. PubMed ID: 4017165
[TBL] [Abstract][Full Text] [Related]
40. [Randomized controlled study of sequential methotrexate and 5-fluorouracil therapy with or without 5'-deoxy-5-fluorouridine against advanced gastrointestinal cancer. Hirosaki Cooperative Study Group for Cancer Chemotherapy].
Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1187-92. PubMed ID: 8031160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]